Dream CIS Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
372
- Stock Symbol
-
223250
- Investments
-
7
- Share Price
-
$2.87
- (As of Thursday Closing)
Dream CIS General Information
Description
DreamCIS Inc operates as a contract research organization. It provides experience services in Therapeutic Areas; Clinical Trial/Late Phase Study; Oncology; Cardiovascular; Endocrinology; and Rare Disease. It provides its services to clinical development; stand alone services; medical devices; and consulting.
Contact Information
Website
www.dreamcis.comCorporate Office
- 130 Sajik-ro, Jongno-gu
- 10th floor, Jeokseon Hyundai Building
- Seoul
- South Korea
Corporate Office
- 130 Sajik-ro, Jongno-gu
- 10th floor, Jeokseon Hyundai Building
- Seoul
- South Korea
Dream CIS Stock Performance
As of 12-Nov-2026, Dream CIS’s stock price is $2.87. Its current market cap is $70.6M with 24.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.87 | $2.99 | $1.63 - $5.91 | $70.6M | 24.6M | 364K | $0.01 |
Dream CIS Financials Summary
As of 30-Jun-2026, Dream CIS has a trailing 12-month revenue of $50.5M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 41,609 | 93,919 | 35,600 | 45,544 |
| Revenue | 50,495 | 46,820 | 42,987 | 36,593 |
| EBITDA | 4,577 | 9,270 | 6,017 | 4,599 |
| Net Income | 227 | 5,008 | 3,870 | 2,860 |
| Total Assets | 103,364 | 112,389 | 80,476 | 68,774 |
| Total Debt | 10,573 | 11,638 | 2,558 | 3,330 |
Dream CIS Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Dream CIS Signals
Dream CIS Investments & Acquisitions (7)
Dream CIS’s most recent deal was a Later Stage VC with Curi Bio for . The deal was made on 02-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Curi Bio | 02-Dec-2025 | Later Stage VC | Discovery Tools (Healthcare) | ||
| Bertis | 26-Jan-2024 | Later Stage VC | Diagnostic Equipment | ||
| T&R Biofab | 22-Dec-2023 | PIPE | Other Devices and Supplies | ||
| G2GBIO | 16-Nov-2023 | Later Stage VC | Drug Discovery | ||
| Cellatoz Therapeutics | 03-May-2023 | Later Stage VC | Drug Discovery |
Dream CIS ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Commercial Services
Industry
Rank
Percentile
Business Support Services
Subindustry
Rank
Percentile
Dream CIS Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Meditip Company | Seoul, South Korea | 2007 |
Dream CIS FAQs
-
When was Dream CIS founded?
Dream CIS was founded in 2000.
-
Where is Dream CIS headquartered?
Dream CIS is headquartered in Seoul, South Korea.
-
What is the size of Dream CIS?
Dream CIS has 372 total employees.
-
What industry is Dream CIS in?
Dream CIS’s primary industry is Other Healthcare Services.
-
Is Dream CIS a private or public company?
Dream CIS is a Public company.
-
What is Dream CIS’s stock symbol?
The ticker symbol for Dream CIS is 223250.
-
What is the current stock price of Dream CIS?
As of 12-Nov-2026 the stock price of Dream CIS is $2.87.
-
What is the current market cap of Dream CIS?
The current market capitalization of Dream CIS is $70.6M.
-
What is Dream CIS’s current revenue?
The trailing twelve month revenue for Dream CIS is $50.5M.
-
What is Dream CIS’s annual earnings per share (EPS)?
Dream CIS’s EPS for 12 months was $0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process